16.07.2021 17:45:00

Albany Molecular Research, Inc. -- Moody's downgrades Curia's (f/k/a AMRI) CFR to B3; affirms first lien ratings at B2; outlook stable

Rating Action: Moody's downgrades Curia's (f/k/a AMRI) CFR to B3; affirms first lien ratings at B2; outlook stable
Read the full article at Moody's